Patents Examined by Frank W Lu
  • Patent number: 11667971
    Abstract: Probe systems and methods are provided for detecting nucleic acid targets using labeled polynucleotide probes and antiprobes that interact together and with complementary targets. These interactions result in signaling changes that indicate target frequency and provide error-checking functions that facilitate single base discrimination. These probe:antiprobe compositions enable real-time PCR detection, end-point detection and microarray detection of microbial species, drug resistant mutants, and cancer related variants. The probe:antiprobe may be an internal probe between two primers or may be a primer-probe. The probe also may be modified by introducing a base mismatch to increase thermodynamic discrimination of a correct versus incorrect target differing by a single base. Probe systems also are provided for use in methods of increasing target amplification and detecting specific single base variants.
    Type: Grant
    Filed: March 17, 2014
    Date of Patent: June 6, 2023
    Inventor: David A. Shafer
  • Patent number: 11662341
    Abstract: Described herein are immune binding proteins and method for obtaining immune binding proteins from genomic or other sources. Also described herein are nucleic acids encoding the immune binding proteins in which the natural multimeric association of chains is maintained in the nucleic acids and the immune binding proteins made therefrom. For example, nucleic acids encoding antibodies that are amplified from a B-cell using the methods described herein maintain the natural pairing of heavy and light chains from the B-cell. This maintenance of pairing (or multimerization) produces libraries and/or repertoires of immune binding proteins that are enriched for useful binding molecules.
    Type: Grant
    Filed: October 9, 2019
    Date of Patent: May 30, 2023
    Assignee: Augmenta Bioworks, Inc.
    Inventors: Marco Antonio Mena, Christopher J. Emig, John Haliburton, Payam Shahi
  • Patent number: 11618892
    Abstract: The present invention relates to a mutant reverse transcriptase (RT) with increased thermal stability relative to the wildtype, a nucleic acid encoding the mutant RT, a cell comprising the mutant RT or the nucleic acid, a kit comprising the mutant RT, the use of the mutant RT for cDNA synthesis, method for reverse transcription of RNA comprising synthesizing cDNA with the use of the mutant RT and a method for detecting an RNA marker in a sample with the use of the mutant RT.
    Type: Grant
    Filed: October 11, 2019
    Date of Patent: April 4, 2023
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Christian Helmut Bell, Harald Sobek, Heiko Walch, Kiyoshi Yasukawa, Misato Baba
  • Patent number: 11603383
    Abstract: The methods described herein provide a means of producing an array of spatially separated proteins. The method relies on covalently attaching each protein of the plurality of proteins to a structured nucleic acid particle (SNAP), and attaching the SNAPs to a solid support.
    Type: Grant
    Filed: March 9, 2022
    Date of Patent: March 14, 2023
    Assignee: Nautilus Biotechnology, Inc.
    Inventors: Dmitriy Gremyachinskiy, Rachel Galimidi, Parag Mallick, Sujal M. Patel
  • Patent number: 11560565
    Abstract: Described herein are DNA-nanostructures that can be used in an assay to detect and/or quantify an analyte of interest. Aspects of the DNA-nanostructure can include a single DNA molecule composed of hairpin structural motifs, an anchor recognition moiety, and a signal moiety, where the anchor recognition moiety and the signal moiety are in effective proximity to each other such that the tethered diffusion of the signal molecule can be altered based upon binding status of the anchor recognition moiety. Also described herein are methods of making and using the DNA-nanostructures.
    Type: Grant
    Filed: June 13, 2019
    Date of Patent: January 24, 2023
    Inventors: Christopher J. Easley, Subramaniam Somasundaram
  • Patent number: 11560592
    Abstract: Provided herein are methods for resetting an array to which a biological sample has been applied that include treating the array with a set of biological sample removal conditions.
    Type: Grant
    Filed: December 10, 2021
    Date of Patent: January 24, 2023
    Assignee: 10x Genomics, Inc.
    Inventors: Jennifer Chew, Zachary Bent, Alvaro J Gonzalez Lozano
  • Patent number: 11542553
    Abstract: The invention relates to methods for pairwise sequencing of a polynucleotide template which result in the sequential determination of nucleotide sequence in two distinct and separate regions of the polynucleotide template.
    Type: Grant
    Filed: August 28, 2020
    Date of Patent: January 3, 2023
    Assignee: Illumina Cambridge Limited
    Inventor: Harold Philip Swerdlow
  • Patent number: 11512344
    Abstract: Provided herein are high-throughput, high-quality methods of consecutive in situ hybridization for analysis of the genome and/or transcriptome in an individual cell with single-molecule sensitivity. In particular, provided herein are methods comprising visualizing individual genomic loci or transcripts as single detectable signals (e.g., fluorescent spots) which remain in place during consecutive hybridization. In each cycle of consecutive hybridization, detectably labeled probes hybridize to the probe used in the previous cycle, and also introduce the binding sites for the probe of the following cycle. Through consecutive cycles of probe hybridization, imaging, and signal removal, different genomic loci or RNA species can be identified by unique detectable signal profiles (e.g., fluorescent spots with unique color sequences). The number of varied color sequences increases exponentially with the number of hybridization cycles, which enables the genome or transcriptome-wide analysis.
    Type: Grant
    Filed: April 25, 2017
    Date of Patent: November 29, 2022
    Assignee: Arizona Board of Regents on behalf of Arizona State University
    Inventor: Jia Guo
  • Patent number: 11505821
    Abstract: The present invention relates to improved processes for production of closed linear deoxyribonucleic acid (DNA), in particular cell-free enzymatic production of closed linear DNA molecules, preferably using a closed linear DNA as a template for DNA synthesis. The invention further relates to a novel closed linear DNA species, suitable for use as a template in the improved processes for production of closed linear DNA. Further, the invention pertains to the intermediate products of the processes, since this enables the production of larger quantities of closed linear DNA from the template than with methods known in the art.
    Type: Grant
    Filed: August 16, 2017
    Date of Patent: November 22, 2022
    Assignee: Touchlight IP Limited
    Inventors: Thomas Adie, Neil Porter, Paul Rothwell
  • Patent number: 11505827
    Abstract: Systems and methods of polynucleotide sequencing are provided. Systems and methods optimize control, speed, movement, and/or translocation of a sample (e.g., a polynucleotide) within, through, or at least partially through a nanopore or a type of protein or mutant protein in order to accumulate sufficient time and current blocking information to identify contiguous nucleotides or plurality of nucleotides in a single-stranded area of a polynucleotide.
    Type: Grant
    Filed: March 12, 2019
    Date of Patent: November 22, 2022
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Timothy Geiser, Randall Davis, Roger Chen
  • Patent number: 11499182
    Abstract: A method for generating amplicon constructs of a target sequence is disclosed, the method comprising providing a target sequence; an oligonucleotide probe, comprising a universal sequence and further comprising, at or towards its 5? end, a target specific sequence capable of hybridising to the reverse complement of a sequence at, or flanking one of the 3? ends of the target sequence; a universal primer, comprising at its 3? end a sequence capable of hybridising to the universal sequence of the oligonucleotide probe and performing a Polymerase Chain Reaction (PCR).
    Type: Grant
    Filed: March 3, 2016
    Date of Patent: November 15, 2022
    Assignee: Salisbury NHS Foundation Trust
    Inventors: Daniel Leonard Ward, Christopher John Mattocks
  • Patent number: 11479815
    Abstract: Described herein is a method of sequencing, comprising: splitting an asymmetrically tagged library into a plurality of subsamples, tagging the adaptor-ligated DNA in the sub-samples with sequence tags that identify the subsamples, optionally pooling the sub-samples, sequencing polynucleotides from each of the tagged sub-samples, or copies of the same, to produce sequence reads each comprising: i. a sub-sample identifier sequence and ii. the sequence of at least part of a fragment in the sample, wherein some of the sequence reads are derived from the top strand of a fragment in the sample and some of the sequence reads of are derived from the bottom strand of the same fragment.
    Type: Grant
    Filed: September 1, 2016
    Date of Patent: October 25, 2022
    Assignee: OXFORD NANOPORE TECHNOLOGIES PLC
    Inventor: Robert Osborne
  • Patent number: 11473142
    Abstract: The present invention relates to, among other things, probes, compositions, methods, and kits for simultaneous, multiplexed detection and quantification of protein and/or nucleic acid expression in a user-defined region of a tissue, user-defined cell, and/or user-defined subcellular structure within a cell that are adaptable for use with existing sequencing technologies.
    Type: Grant
    Filed: September 16, 2021
    Date of Patent: October 18, 2022
    Assignee: NanoString Technologies, Inc.
    Inventors: Joseph M. Beechem, Dae Kim, Margaret Hoang, Mark Gregory, Erin Piazza, Denise Zhou
  • Patent number: 11474065
    Abstract: An object of the present invention is to provide a biomolecule measuring device that can decrease the influence of crosstalk between chambers. A biomolecule measuring device according to the present invention supplies, to electrodes equipped on chambers, voltages modulated differently to each other.
    Type: Grant
    Filed: April 11, 2017
    Date of Patent: October 18, 2022
    Assignee: Hitachi High-Tech Corporation
    Inventors: Yoshimitsu Yanagawa, Yusuke Goto, Michiru Fujioka
  • Patent number: 11459606
    Abstract: The invention relates to adaptors for sequencing nucleic acids. The adaptors may be used to generate single stranded constructs of nucleic acid for sequencing purposes. Such constructs may contain both strands from a double stranded deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) template. The invention also relates to the constructs generated using the adaptors, methods of making the adaptors and constructs, as well as methods of sequencing double stranded nucleic acids.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: October 4, 2022
    Assignee: Oxford Nanopore Technologies PLC
    Inventor: Brian McKeown
  • Patent number: 11459619
    Abstract: A method for identifying a predefined target organism includes extracting a nucleic acid from a sample to form an extracted nucleic acid, amplifying the extracted nucleic acid to form a nucleic acid amplicon, tagging the nucleic acid amplicon with a capture probe and a detector partner to form a detector partner-nucleic acid amplicon-capture probe complex, and performing a detection assay on the detector partner-nucleic acid amplicon-capture probe complex to identify whether the predefined target organism is present in the sample.
    Type: Grant
    Filed: May 6, 2019
    Date of Patent: October 4, 2022
    Assignee: The Johns Hopkins University
    Inventors: Mekbib Astatke, Amy L. Connolly
  • Patent number: 11441197
    Abstract: As demonstrated herein, when composite transcription factor binding sites do not function synergistically, mammalian promoters can be constructed according to simple design rules. Host-cell transcriptional machinery components were analyzed in silico to identify transcription factors with desired expression dynamics. Cognate binding sites were then comprehensively tested in homotypic and heterotypic architectures to assess modularity and determine the transcriptional activity exhibited by a single copy of each site. When elements were specifically selected to prevent combinatorial interactions, heterotypic promoter activities could be accurately modeled simply as a function of constituent binding site copy numbers. As binding site order, spacing, and orientation had minimal effect on promoter activity, blocks could be optimally combined and arranged in silico according to context-specific design-criteria.
    Type: Grant
    Filed: April 19, 2018
    Date of Patent: September 13, 2022
    Assignee: MedImmune Limited
    Inventors: Adam J. Brown, David C. James, Suzanne J. Gibson, Diane Hatton
  • Patent number: 11427867
    Abstract: The invention is a method of sequencing polymers in which the sequence of one or more polymers is determined through an emergent property of the binding interactions of a repertoire of molecular probes to the polymer(s).
    Type: Grant
    Filed: May 29, 2019
    Date of Patent: August 30, 2022
    Assignee: XGENOMES CORP.
    Inventor: Kalim Mir
  • Patent number: 11427854
    Abstract: A method for collecting microorganisms when contained in a fluid includes (i) introducing the fluid into a cavity of a collecting device via at least one admission duct, (ii) capturing the microorganisms when contained in the fluid with a set of beads retained in the cavity as the fluid passes through the set of beads, (iii) evacuating the fluid from the cavity via at least one evacuating duct, (iv) introducing a reaction liquid into the cavity via at least one admission channel, (v) collecting the microorganisms from the set of beads with the reaction liquid as the reaction liquid passes through the set of beads, and (vi) evacuating the reaction liquid from the cavity via at least one evacuating channel.
    Type: Grant
    Filed: February 21, 2020
    Date of Patent: August 30, 2022
    Assignee: BIOMERIEUX
    Inventors: Michel Guy, Hervé Rostaing
  • Patent number: 11421266
    Abstract: The present disclosure relates to a set of at least 100 single-stranded oligonucleotide probes directed against (or complementary to) portions of a genomic target sequence of interest. The present disclosure also relates to a method of detecting a genomic target sequence of interest using the set of oligonucleotide probes and a method of generating the set of oligonucleotide probes. Further, the present disclosure relates to a kit comprising the set of oligonucleotide probes and at least one further component.
    Type: Grant
    Filed: March 25, 2020
    Date of Patent: August 23, 2022
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Frank Bergmann, Walter Eberle, Thomas Fischer, Herbert von der Eltz